Status:
COMPLETED
A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19
Lead Sponsor:
Portsmouth Hospitals NHS Trust
Conditions:
SARS-CoV Infection
Eligibility:
All Genders
16+ years
Brief Summary
Point of care testing is urgently required to enable the immediate detection of SARS-CoV-2 infection to allow effective transmission prevention precautions to succeed.
Detailed Description
The Coronacheck device is a hand-held, portable, point-of-care device which will allow the safe collection of EBC. It provides an automated platform for the detection of SARS-CoV-2 using an existing s...
Eligibility Criteria
Inclusion
- o Any adult (≥ 16 years of age) who is:
- undergoing a swab for possible SARS-CoV-2 infection
- willing and able to give informed consent for participation in the study
- unlikely to suffer harm as a result of testing in the opinion of the investigator
Exclusion
- o Participants receiving:
- invasive ventilation, non-invasive ventilation or nasal high flow oxygen
- supplementary oxygen with symptomatic hypoxia or oxygen saturations ≤92% (≤88% in COPD) despite 4L oxygen via nasal cannulae
- unable to comprehend the study or provide informed consent
Key Trial Info
Start Date :
October 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 2 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04742712
Start Date
October 27 2020
End Date
February 2 2021
Last Update
April 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Portsmouth Hospitals NHS Trust
Portsmouth, Hampshire, United Kingdom, PO6 3LY